Anzeige
Meldung des Tages: Verdoppelt – und noch nicht am Ziel? Dieser Rohstoff-Explorer profitiert vom Antimon-Boom

Evogene News

Aktie
WKN:  A0Q7UP ISIN:  IL0011050551 US-Symbol:  EVGN Branche:  Biotechnologie Land:  Israel
0,7504 $
+0,00 $
0,00%
0,6461 € 05.03.26
Depot/Watchlist
Marktkapitalisierung *
4,43 Mio. €
Streubesitz
97,15%
KGV
-
Index-Zuordnung
-

Evogene News

09.03.26 - PR Newswire
Evogene to Present Its Pharma Discovery Achievements at BIO-Europe Spring 2026
Evogene to Present Its Pharma Discovery Achievements at BIO-​Europe Spring 2026 PR Newswire
05.03.26 - PR Newswire
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results
Evogene Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire
25.02.26 - PR Newswire
Evogene Releases CEO Letter to Shareholders
Evogene Releases CEO Letter to Shareholders PR Newswire
19.02.26 - PR Newswire
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release PR Newswire
17.02.26 - PR Newswire
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
Evogene and Queensland University of Technology (QUT) Announce a Collaboration to Advance AI-Driven Cancer Therapeutics PR Newswire
11.02.26 - PR Newswire
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-Derived Inflammatory Diseases
Evogene, Systasy and LMU University Hospital Munich Announce a Collaboration to Develop Novel Therapies for Neutrophil-​Derived Inflammatory Diseases PR Newswire
10.02.26 - PR Newswire
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds PR Newswire
10.02.26 - PR Newswire
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™
Evogene Announces Expanded Collaboration with Google Cloud to Integrate AI Agents into ChemPass AI™ PR Newswire
09.02.26 - PR Newswire
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board PR Newswire
04.02.26 - PR Newswire
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-​Based Therapeutic for Renal and Lung Cancer PR ...
07.01.26 - PR Newswire
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders
Evogene and Unravel Biosciences Announce Collaboration to Develop a First-​in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders PR Newswire
30.12.25 - PR Newswire
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development
Evogene Announces Appointment of Dr. Olga Nissan as its Vice President of Business Development PR Newswire
20.11.25 - PR Newswire
Evogene Reports Third Quarter 2025 Financial Results
Evogene Reports Third Quarter 2025 Financial Results PR Newswire
11.11.25 - PR Newswire
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming PR Newswire
06.11.25 - PR Newswire
Evogene Schedules Third Quarter 2025 Financial Results Release
Evogene Schedules Third Quarter 2025 Financial Results Release PR Newswire
28.08.25 - PR Newswire
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York PR Newswire
19.08.25 - PR Newswire
Evogene Reports Second Quarter 2025 Financial Results
Evogene Reports Second Quarter 2025 Financial Results PR Newswire
12.08.25 - PR Newswire
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases PR Newswire
29.07.25 - PR Newswire
Evogene Schedules Second Quarter 2025 Financial Results Release
Evogene Schedules Second Quarter 2025 Financial Results Release PR Newswire
08.07.25 - PR Newswire
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL PR Newswire

Newssuche

Videos

newspaper
04.03.26 -6,19%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »